20-007 - Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's DiseaseStatus: open
A Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy, Safety and Tolerability of ABBV-951 to Oral Carbidopa/Levodopa in Advanced Parkinson's Disease Patients
Treatment for Parkinson's Disease
Parkinson's Disease clinical trial testing a new compound of carbidopa/levodopa that is delivered by a 24 continuous infusion. Previous studies with this new drug have been promising and the purpose of this study is to assess the efficacy, safety, and the tolerability of the drug. Study activities include neurological and physical exams, questionnaire, physical function tests, blood tests.
SponsorsThis trial is sponsored by AbbVie.
Interested in Clinical Trial?
Providers Associated With This Trial
- Daniel D. Dees, M.D.NeurologistAssistant Professor of Neurology